Analysen von Ryan Martins
| 09.12.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 08.12.10 | Celgene overweight | Barclays Capital | |
| 01.12.10 | Amgen overweight | Barclays Capital | |
| 22.11.10 | Amgen overweight | Barclays Capital | |
| 16.11.10 | Human Genome Sciences overweight | Barclays Capital | |
| 08.11.10 | Ionis Pharmaceuticals overweight | Barclays Capital | |
| 08.11.10 | Gilead Sciences equal-weight | Barclays Capital | |
| 05.11.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
|
Werbung
|
|||
| 28.10.10 | Biogen equal-weight | Barclays Capital | |
| 27.10.10 | Amgen overweight | Barclays Capital | |
| 26.10.10 | Sanofi equal-weight | Barclays Capital | |
| 22.10.10 | Biogen equal-weight | Barclays Capital | |
| 20.10.10 | Amgen overweight | Barclays Capital | |
| 11.10.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 07.10.10 | Halozyme Therapeutics overweight | Barclays Capital | |
| 30.09.10 | Biogen equal-weight | Barclays Capital | |
| 27.09.10 | Amylin Pharmaceuticals overweight | Barclays Capital | |
| 22.09.10 | Amgen overweight | Barclays Capital | |
| 16.09.10 | Amgen overweight | Barclays Capital | |
| 15.09.10 | Gilead Sciences equal-weight | Barclays Capital | |